Michael G. Carter, Director at Oncternal Therapeutics, holds 71.95K shares in Oncternal Therapeutics (Ticker: ONCT), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, Michael G. Carter Bought ― shares of Oncternal Therapeutics on Sep 02, 2020 for an estimated value of 150.00K.
What is the percentage of profitable transactions made by Michael G. Carter?
The percentage of profitable transactions made by Michael G. Carter is ―.
What is the average return per transaction made by Michael G. Carter?
The average return per transaction made by Michael G. Carter is ―.
What stocks does Michael G. Carter hold?
Michael G. Carter holds: ONCT, SNTS stocks.
What was Michael G. Carter’s latest transaction?
Michael G. Carter latest transaction was an Informative Buy of $150.00K.
What was Michael G. Carter's most profitable transaction?
Michael G. Carter’s most profitable transaction was an Informative Buy of ONCT stock on September 2, 2020. The return on the trade was 113.20%.
What is Michael G. Carter's role in Oncternal Therapeutics?
Michael G. Carter's role in Oncternal Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.